Ieq Capital LLC reduced its holdings in Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO) by 11.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,560 shares of the basic materials company’s stock after selling 1,058 shares during the quarter. Ieq Capital LLC’s holdings in Cameco were worth $352,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. MetLife Investment Management LLC bought a new stake in shares of Cameco in the 1st quarter worth approximately $2,131,000. Vanguard Capital Wealth Advisors purchased a new position in shares of Cameco in the fourth quarter worth approximately $839,000. Northwest & Ethical Investments L.P. increased its position in shares of Cameco by 50.0% in the first quarter. Northwest & Ethical Investments L.P. now owns 42,487 shares of the basic materials company’s stock worth $1,750,000 after acquiring an additional 14,154 shares in the last quarter. Kayne Anderson Capital Advisors LP increased its position in shares of Cameco by 41.6% in the first quarter. Kayne Anderson Capital Advisors LP now owns 40,407 shares of the basic materials company’s stock worth $1,663,000 after acquiring an additional 11,879 shares in the last quarter. Finally, Nicholson Meyer Capital Management Inc. purchased a new position in shares of Cameco in the first quarter worth approximately $350,000. 70.21% of the stock is currently owned by institutional investors.
Cameco Stock Down 0.6%
Shares of NYSE CCJ opened at $75.85 on Friday. The firm has a market capitalization of $33.02 billion, a PE ratio of 87.18 and a beta of 1.04. The company has a current ratio of 2.96, a quick ratio of 2.00 and a debt-to-equity ratio of 0.15. Cameco Corporation has a 1 year low of $35.00 and a 1 year high of $83.02. The firm’s 50-day moving average is $75.64 and its 200-day moving average is $58.73.
Analysts Set New Price Targets
Several research firms have recently weighed in on CCJ. Raymond James Financial reissued an “outperform” rating on shares of Cameco in a research report on Tuesday. Glj Research reaffirmed a “buy” rating and set a $75.27 price objective on shares of Cameco in a research report on Thursday, June 12th. BMO Capital Markets reissued an “outperform” rating on shares of Cameco in a research report on Friday, August 29th. Royal Bank Of Canada upped their price objective on shares of Cameco from $100.00 to $110.00 and gave the stock an “outperform” rating in a report on Friday, August 1st. Finally, TD Securities reiterated a “buy” rating on shares of Cameco in a research note on Tuesday, August 5th. Two analysts have rated the stock with a Strong Buy rating and twelve have issued a Buy rating to the company’s stock. According to MarketBeat.com, Cameco has an average rating of “Buy” and an average price target of $83.32.
Get Our Latest Stock Analysis on CCJ
Cameco Profile
Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
Featured Stories
- Five stocks we like better than Cameco
- Expert Stock Trading Psychology Tips
- Why DocuSign Could Be a SaaS Value Play After Q2 Earnings
- Airline Stocks – Top Airline Stocks to Buy Now
- Lululemon Share Price Has Plenty of Room Left to Fall
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Advanced Micro Devices’ 2026 Forecasts Are Way Too Low
Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO).
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.